Novo Nordisk gains approval to sell weight-loss drug Wegovy in China
Market Watch • 601 days
Low Materiality0/10
Information
Novo Nordisk has gained approval to start marketing its blockbuster weight-loss drug Wegovy in China...
Original sourceAI Summary
- Novo Nordisk gains approval to market weight-loss drug Wegovy in China. Price Impact Rating: Bullish Impact Horizon Rating: Short-term Type: Corporate Developments
Market-Moving
- Novo Nordisk gains approval to market weight-loss drug Wegovy in China.
Key Facts
- Novo Nordisk gains approval to market weight-loss drug Wegovy in China.